Terms: = Prostate cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1 AND Prognosis
13 results:
1. The Impact of a History of Different Other cancers on the Long-Term Outcomes of Patients with Gallbladder cancer: A Propensity Score-Adjusted, Population-Based Study.
Wang J; Zhang C; Yan D
Technol Cancer Res Treat; 2023; 22():15330338231183937. PubMed ID: 37394878
[TBL] [Abstract] [Full Text] [Related]
2. runx1 Is Regulated by Androgen Receptor to Promote cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast cancer.
Fernández NB; Sosa SM; Roberts JT; Recouvreux MS; Rocha-Viegas L; Christenson JL; Spoelstra NS; Couto FL; Raimondi AR; Richer JK; Rubinstein N
Cells; 2023 Jan; 12(3):. PubMed ID: 36766786
[TBL] [Abstract] [Full Text] [Related]
3. The Comprehensive Analysis of Hub Gene ARRB2 in prostate cancer.
Zhou B; Song H; Xu W; Zhang Y; Liu Y; Qi W
Dis Markers; 2022; 2022():8518378. PubMed ID: 36284990
[TBL] [Abstract] [Full Text] [Related]
4. The impact of the COVID-19 pandemic on the short-term survival of patients with cancer in Northern Portugal.
Morais S; Antunes L; Rodrigues J; Fontes F; Bento MJ; Lunet N
Int J Cancer; 2021 Jul; 149(2):287-296. PubMed ID: 33634852
[TBL] [Abstract] [Full Text] [Related]
5. Clinical characteristics and overall survival nomogram of second primary malignancies after prostate cancer, a SEER population-based study.
Liu Y; Zhang P; Zhang Y; Zheng L; Xu W; Hou D; Kang Z
Sci Rep; 2021 Jan; 11(1):1293. PubMed ID: 33446816
[TBL] [Abstract] [Full Text] [Related]
6. Long non-coding RNA FENDRR reduces prostate cancer malignancy by competitively binding miR-18a-5p with runx1.
Zhang G; Han G; Zhang X; Yu Q; Li Z; Li Z; Li J
Biomarkers; 2018 Jul; 23(5):435-445. PubMed ID: 29465000
[TBL] [Abstract] [Full Text] [Related]
7. Dietary inflammatory index and prostate cancer survival.
Zucchetto A; Gini A; Shivappa N; Hébert JR; Stocco C; Dal Maso L; Birri S; Serraino D; Polesel J
Int J Cancer; 2016 Dec; 139(11):2398-404. PubMed ID: 27242333
[TBL] [Abstract] [Full Text] [Related]
8. Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells.
Chatterji T; Varkaris AS; Parikh NU; Song JH; Cheng CJ; Schweppe RE; Alexander S; Davis JW; Troncoso P; Friedl P; Kuang J; Lin SH; Gallick GE
Oncotarget; 2015 Apr; 6(12):10175-94. PubMed ID: 25868388
[TBL] [Abstract] [Full Text] [Related]
9. Changes in prognostic and therapeutic parameters in prostate cancer from an epidemiological view over 20 years.
Dörr M; Hölzel D; Schubert-Fritschle G; Engel J; Schlesinger-Raab A
Oncol Res Treat; 2015; 38(1-2):8-14. PubMed ID: 25633491
[TBL] [Abstract] [Full Text] [Related]
10. runx1, an androgen- and EZH2-regulated gene, has differential roles in AR-dependent and -independent prostate cancer.
Takayama K; Suzuki T; Tsutsumi S; Fujimura T; Urano T; Takahashi S; Homma Y; Aburatani H; Inoue S
Oncotarget; 2015 Feb; 6(4):2263-76. PubMed ID: 25537508
[TBL] [Abstract] [Full Text] [Related]
11. Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer.
Tomioka A; Tanaka N; Yoshikawa M; Miyake M; Anai S; Chihara Y; Okajima E; Hirayama A; Hirao Y; Fujimoto K
BMC Urol; 2014 Apr; 14():33. PubMed ID: 24773608
[TBL] [Abstract] [Full Text] [Related]
12. Increased non-prostate cancer death risk in clinically diagnosed prostate cancer.
van Leeuwen PJ; Otto SJ; Kranse R; Roobol MJ; Bul M; Zhu X; de Koning H; Schröder FH
BJU Int; 2012 Jul; 110(2):188-94. PubMed ID: 22288823
[TBL] [Abstract] [Full Text] [Related]
13. Chromatin structural elements and chromosomal translocations in leukemia.
Zhang Y; Rowley JD
DNA Repair (Amst); 2006 Sep; 5(9-10):1282-97. PubMed ID: 16893685
[TBL] [Abstract] [Full Text] [Related]
